Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 1;10(6):a036541.
doi: 10.1101/cshperspect.a036541.

Cancer Genetic Counseling-Current Practice and Future Challenges

Jaclyn Schienda  1 , Jill Stopfer  1
Affiliations
Review

Cancer Genetic Counseling-Current Practice and Future Challenges

Jaclyn Schienda et al. Cold Spring Harb Perspect Med. .

Abstract

Cancer genetic counseling practice is rapidly evolving, with services being provided in increasingly novel ways. Pretest counseling for cancer patients may be abbreviated from traditional models to cover the elements of informed consent in the broadest of strokes. Genetic testing may be ordered by a cancer genetics professional, oncology provider, or primary care provider. Increasingly, direct-to-consumer testing options are available and utilized by consumers anxious to take control of their genetic health. Finally, genetic information is being used to inform oncology care, from surgical decision-making to selection of chemotherapeutic agent. This review provides an overview of the current and evolving practice of cancer genetic counseling as well as opportunities and challenges for a wide variety of indications in both the adult and pediatric setting.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. 2015. Committee opinion no. 634: hereditary cancer syndromes and risk assessment. Obstet Gynecol 125: 1538–1543. 10.1097/01.AOG.0000466373.71146.51 - DOI - PubMed
    1. Abida W, Cheng ML, Armenia J, Middha S, Autio KA, Vargas HA, Rathkopf D, Morris MJ, Danila DC, Slovin SF, et al. 2019. Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade. JAMA Oncol 5: 471–478. 10.1001/jamaoncol.2018.5801 - DOI - PMC - PubMed
    1. Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, et al. 2015. Parent decision-making around the genetic testing of children for germline TP53 mutations. Cancer 121: 286–293. 10.1002/cncr.29027 - DOI - PubMed
    1. Almqvist EW, Brinkman RR, Wiggins S, Hayden MR, Canadian Collaborative Study of Predictive Testing. 2003. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clin Genet 64: 300–309. 10.1034/j.1399-0004.2003.00157.x - DOI - PubMed
    1. Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, Berg JS, Biswas S, Bowling KM, Conlin LK, et al. 2016. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet 99: 247 10.1016/j.ajhg.2016.06.001 - DOI - PMC - PubMed